Institution
Clinical Trial Service Unit
About: Clinical Trial Service Unit is a based out in . It is known for research contribution in the topics: Population & Stroke. The organization has 428 authors who have published 1387 publications receiving 181920 citations.
Papers published on a yearly basis
Papers
More filters
TL;DR: The sources and methods used in compiling the cancer statistics in 185 countries are reviewed, and uncertainty intervals are now provided for the estimated sex‐ and site‐specific all‐ages number of new cancer cases and cancer deaths.
Abstract: Estimates of the worldwide incidence and mortality from 36 cancers and for all cancers combined for the year 2018 are now available in the GLOBOCAN 2018 database, compiled and disseminated by the International Agency for Research on Cancer (IARC). This paper reviews the sources and methods used in compiling the cancer statistics in 185 countries. The validity of the national estimates depends upon the representativeness of the source information, and to take into account possible sources of bias, uncertainty intervals are now provided for the estimated sex- and site-specific all-ages number of new cancer cases and cancer deaths. We briefly describe the key results globally and by world region. There were an estimated 18.1 million (95% UI: 17.5-18.7 million) new cases of cancer (17 million excluding non-melanoma skin cancer) and 9.6 million (95% UI: 9.3-9.8 million) deaths from cancer (9.5 million excluding non-melanoma skin cancer) worldwide in 2018.
4,924 citations
TL;DR: It is found that variations in local treatment that substantially affect the risk of locoregional recurrence could also affect long-term breast cancer mortality, and that avoidance of a local recurrence in the conserved breast is recommended.
4,743 citations
TL;DR: A sufficiently high risk of stroke (perhaps because of age, blood pressure, or, in particular, history of cerebrovascular disease) may be the clearest indication for antihypertensive treatment.
4,488 citations
TL;DR: The DBP results suggest that for the large majority of individuals, whether conventionally "hypertensive" or "normotensive", a lower blood pressure should eventually confer a lower risk of vascular disease.
4,397 citations
Auckland University of Technology1, Institute for Health Metrics and Evaluation2, National Institutes of Health3, Clinical Trial Service Unit4, Columbia University Medical Center5, University of Miami6, Washington State Institute for Public Policy7, Copenhagen University Hospital8, National University of Ireland, Galway9, National University of Singapore10, University of Auckland11, Capital Medical University12, Imperial College London13
TL;DR: Regional and country-specific estimates of stroke incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) lost by age group and country income level are calculated, to improve understanding of stroke determinants and burden worldwide.
3,127 citations
Authors
Showing all 428 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Salim Yusuf | 231 | 1439 | 252912 |
| Richard Peto | 183 | 683 | 231434 |
| Cornelia M. van Duijn | 183 | 1030 | 146009 |
| Rory Collins | 162 | 489 | 193407 |
| Naveed Sattar | 155 | 1326 | 116368 |
| Timothy J. Key | 146 | 808 | 90810 |
| John Danesh | 135 | 394 | 100132 |
| Andrew J.S. Coats | 127 | 820 | 94490 |
| Valerie Beral | 114 | 471 | 53729 |
| Mike Clarke | 113 | 1037 | 164328 |
| Robert Clarke | 111 | 512 | 90049 |
| Robert U. Newton | 109 | 753 | 42527 |
| Richard Gray | 109 | 808 | 78580 |
| Braxton D. Mitchell | 102 | 558 | 49599 |
| Naomi E. Allen | 101 | 364 | 37057 |